Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust and a clinical academic at Imperial College London.
She leads a research group at the National Heart and Lung Institute with a focus on clinical trials that impact the care of patients with cardiovascular disease. She believes in the rigorous testing of clinical practice and the use of evidence-based medicine in all aspects of medical care.
She designed, conducted and led ORBITA, the first randomised placebo-controlled trial of coronary angioplasty. She is lead author of the primary publication in The Lancet and the two secondary analyses both published in Circulation.
She is the NIHR CRN North West London Cardiovascular speciality lead and is actively involved in the development and recruitment for a number of multi-centre international clinical trials.
